Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Does the Shoe Fit? Selecting Robotic IV Technology for Pediatric Sites
Track:
Educational Sessions (CE)
Program Code: 216-L04
Date: Monday, December 7, 2009
Time: 2:00 PM to 5:00 PM EST
Location:
Titian 2204
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Rita Jew, PharmD, Executive Director, Pharmacy and Clinical Nutrition Services, Children's Hospital of Orange County
Description
Planned in cooperation with the ASHP Section of Pharmacy Informatics and Technology
ACPE Activity #204-000-09-216-L04P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: Luci Power, BS, MS, Senior Pharmacy Consultant, Power Enterprises, San Francisco, CA
2:00 p.m. - 2:05 p.m.
Announcements
2:05 p.m. - 2:10 p.m.
Survey of Audience on Selection Process Points for Robotic IV Technology
Luci Power
2:10 p.m. - 2:40 p.m.
Selection Process: Evaluation Criteria for Robotic IV Automated Compounding-What Will a Robot Do for You?
Winson SooHoo, RPh, MBA, Director of Pharmacy Services, The Children's Hospital of Philadelphia, Philadelphia, PA
2:40 p.m. - 2:45 p.m.
Survey of Audience on Financial Process Points for Robotic IV Automated Compounding
Luci Power
2:45 p.m. - 3:15 p.m.
Financial Considerations in Evaluating Robotic IV Automated Compounding-How Can the Robot Pay for Itself?
Kevin D. Jones, RPh, MBA, Director of Pharmacy, Primary Children's Medical Center, Salt Lake City, UT
3:15 p.m. - 3:20 p.m.
Survey of Audience on Failure Mode and Effects Analysis Process
Luci Power
3:20 p.m. - 3:50 p.m.
Failure Mode and Effects Analysis Prior to Implementing Robotic IV Automated Compounding-What Can Go Wrong Will Go Wrong! How Can I Anticipate?
Rita K. Jew, PharmD, FASHP,, Executive Director, Pharmacy and Clinical Nutrition Services, Children's Hospital of Orange County, Orange, CA
3:50 p.m. - 4:00 p.m.
Break
4:00 p.m. - 4:20 p.m.
Implementation Strategies for Robotic IV Automated Compounding
Grace Magedman, PharmD, Pharmacy Operations Manager, Children's Hospital of Orange County, Orange, CA
4:20 p.m. - 4:50 p.m.
Panel Discussion on Key Points
4:50 p.m. - 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-216-L04P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: Luci Power, BS, MS, Senior Pharmacy Consultant, Power Enterprises, San Francisco, CA
2:00 p.m. - 2:05 p.m.
Announcements
2:05 p.m. - 2:10 p.m.
Survey of Audience on Selection Process Points for Robotic IV Technology
Luci Power
2:10 p.m. - 2:40 p.m.
Selection Process: Evaluation Criteria for Robotic IV Automated Compounding-What Will a Robot Do for You?
Winson SooHoo, RPh, MBA, Director of Pharmacy Services, The Children's Hospital of Philadelphia, Philadelphia, PA
2:40 p.m. - 2:45 p.m.
Survey of Audience on Financial Process Points for Robotic IV Automated Compounding
Luci Power
2:45 p.m. - 3:15 p.m.
Financial Considerations in Evaluating Robotic IV Automated Compounding-How Can the Robot Pay for Itself?
Kevin D. Jones, RPh, MBA, Director of Pharmacy, Primary Children's Medical Center, Salt Lake City, UT
3:15 p.m. - 3:20 p.m.
Survey of Audience on Failure Mode and Effects Analysis Process
Luci Power
3:20 p.m. - 3:50 p.m.
Failure Mode and Effects Analysis Prior to Implementing Robotic IV Automated Compounding-What Can Go Wrong Will Go Wrong! How Can I Anticipate?
Rita K. Jew, PharmD, FASHP,, Executive Director, Pharmacy and Clinical Nutrition Services, Children's Hospital of Orange County, Orange, CA
3:50 p.m. - 4:00 p.m.
Break
4:00 p.m. - 4:20 p.m.
Implementation Strategies for Robotic IV Automated Compounding
Grace Magedman, PharmD, Pharmacy Operations Manager, Children's Hospital of Orange County, Orange, CA
4:20 p.m. - 4:50 p.m.
Panel Discussion on Key Points
4:50 p.m. - 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
LEARNER OUTCOMES:
- Compare robotic IV compounding to manual compounding.
- Describe the Failure Mode and Effects Analysis (FMEA) process used prior to the implementation of the robotic IV automation.
- Describe the robotic IV automation available for compounding IV medication.
- Identify challenges to the implementation of robotic technology in pediatric sites.
- List the advantages of robotic IV compounding that may be used to justify the cost of the technology.
This session is a part of:
Handout Online
